Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Amortization of Deferred Charges (2016 - 2024)

Skinvisible's Amortization of Deferred Charges history spans 14 years, with the latest figure at $12814.0 for Q4 2024.

  • On a quarterly basis, Amortization of Deferred Charges changed 0.01% to $12814.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $50973.0, a 96.01% decrease, with the full-year FY2024 number at $50973.0, down 96.01% from a year prior.
  • Amortization of Deferred Charges hit $12814.0 in Q4 2024 for Skinvisible, roughly flat from $12813.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for SKVI hit a ceiling of $1.2 million in Q1 2023 and a floor of $12673.0 in Q1 2024.
  • Historically, Amortization of Deferred Charges has averaged $165021.0 across 5 years, with a median of $165067.0 in 2020.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 651.89% in 2023 and later crashed 98.98% in 2024.
  • Tracing SKVI's Amortization of Deferred Charges over 5 years: stood at $168624.0 in 2020, then dropped by 10.88% to $150276.0 in 2021, then grew by 9.98% to $165276.0 in 2022, then crashed by 92.25% to $12813.0 in 2023, then rose by 0.01% to $12814.0 in 2024.
  • Business Quant data shows Amortization of Deferred Charges for SKVI at $12814.0 in Q4 2024, $12813.0 in Q3 2024, and $12673.0 in Q2 2024.